Western researchers have discovered a protein with the never-before-seen ability to stop DNA damage in its tracks. The finding could provide the foundation for developing everything from vaccines against cancer to crops that can withstand the …
Research
I am Dr. Chil-Yong Kang. Ask Me Anything.
Western professor Dr. Chil-Yong Kang of the Schulich School of Medicine & Dentistry joined the Reddit community on Friday, answering questions about the Phase I clinical trial of the Sumagen HIV/AIDS vaccine, as part of IamA/Ask Me Anything (AMA).
Field School glimpses into Roman Empire’s past, students’ futures
Western researchers Elizabeth Greene and Alexander Meyer, along with nine Classical Studies students, journeyed 6,000 kilometres and nearly 2,000 years for the experience of a lifetime.
New network would unite city’s medical community
Excitement is growing among partners in the Medical Innovation and Commercialization Network after the venture received encouragement from a city council committee last month to forge ahead with the development of a governance structure.
$1-million gift to support Lawrence Centre
A prominent London business leader known for his faith in the ‘virtuous cycle’ has put that belief into action by donating $1 million to the Ivey Business School which will support public policy and leadership education.
HIV vaccine produces no adverse effects in trials
A Phase I clinical trial of a Western-led preventative HIV vaccine has been successfully completed with no adverse effects in all patients.
Study: Education drives health behavior changes after falling ill
Better-educated middle-aged Americans are less likely to smoke and more apt to be physically active than their less-educated peers. They are also more inclined to make healthy changes — in general and in the face of new medical conditions — and adhere to them, according to a new study in the September issue of the Journal of Health and Social Behavior.
Study: Antibody treats Crohn’s disease, ulcerative colitis
An international clinical trial led by Western Epidemiology and Biostatistics professor Dr. Brian Feagan has found the antibody vedolizumab is an effective treatment for those suffering from ulcerative colitis and Crohn’s disease.
Martin Sheen to headline Leaders in Innovation Dinner
Award-winning actor, social activist and humanitarian Martin Sheen will headline the annual Leaders in Innovation Dinner celebrating research excellence at Western’s Robarts Research Institute on Nov. 18 at the London Convention Centre.
Initiative centres on concussions discussion
“The bottom line is concussions suck.”
Fulbright winner headed to Vanderbilt University
James Crimmins is looking forward to a new prospect – calling Vanderbilt University in Nashville, Tenn., home for the next academic year.
Funding helps Engineering professor CREATE opportunities
MONTREAL, Quebec — Western Engineering professor Xianbin Wang, a Canada Research Chair in Wireless Communications, has been named among 15 initiatives receiving a portion of $24 million in funding through the Natural Sciences and Engineering Research Council of Canada (NSERC)’s Collaborative Research and Training Experience (CREATE) initiative.
Researchers: Unresponsive patient communicates after 12 years of ‘silence’
Western researchers have furthered their game-changing neuroimaging techniques in communicating with patients believed to be in a vegetative state by connecting with an individual that has proved otherwise unresponsive for the past 12 years.